Divi's Laboratories

Divi's Laboratories

DIVISLAB

 ₹ 4,134.55
 ₹ 21.55
0.52%

Divi's Laboratories  
Market Sentiment

TimelineReturnsVolume
Daily0.52%6,93,482
Weekly5.72%18,31,682
Monthly8.41%98,21,833

Divi's Laboratories  
Performance

TimelineDailyWeeklyMonthly
DIVISLAB0.52%5.72%8.41%
Index-3.57%-1.42%-1.14%
Peer Avg.-0.10%0.77%2.21%
*Avg of index constituents

Divi's Laboratories  
Fundamentals

TimelinePEPBEV/EBIDTAROEROCEDiv. Yield
DIVISLAB39.579.9821.9228.1535.080.90
Index36.206.7717.2517.8919.691.20
Peer Avg.39.554.7512.3513.5917.020.87
*Avg of index constituents

Divi's Laboratories  
Key Metrics

MetricsSales GrowthProfit GrowthROEROCE
FY '21-2229.59%50.02%28.1535.08
FY '20-2128.61%43.27%23.7331.86
FY '19-208.95%2.38%19.2525.29

Divi's Laboratories  
Shareholding Pattern

PromotersFIIDIIPublicOthers
Promoters : 51.94%
FII : 18.45%
DII : 18.32%
Public : 11.28%
Others : 0.01%

Divi's Laboratories  
Profit & Loss

MetricsSalesExpenditureEBITDAPAT
FY '21-228,919.835,041.893,992.912,954.49
FY '20-216,884.014,043.032,904.031,969.51
FY '19-205,352.493,532.682,009.561,374.62
All values are in crores

Divi's Laboratories  
Peer Comparison

MetricsSalesExpenditureEBITDAPAT
DIVISLAB8,919.835,041.893,992.912,954.49
SHREECEM14,657.7210,982.504,219.502,356.61
DLF4,885.473,104.512,292.921,089.49
All values are in crores

Divi's Laboratories  
Similar Stocks

Cipla

Cipla

CIPLA

 ₹ 1,485.95
- ₹ 3.20
-0.21%
Dr. Reddy's Laboratories
 ₹ 5,875.60
- ₹ 22.10
-0.37%
Lupin

Lupin

LUPIN

 ₹ 1,627.35
- ₹ 5.30
-0.32%
Torrent Pharmaceuticals
 ₹ 2,658.35
- ₹ 34.55
-1.28%
Glaxosmithkline Pharmaceuticals
 ₹ 2,473.30
- ₹ 0.25
-0.01%

Divi's Laboratories Share Price

Divi's Laboratories Limited is an Indian company that manufactures and markets active ingredients (APIs), intermediates and nutrients for export. The company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to its generic business, the Company supports pharmaceutical companies through custom synthesis businesses in the commercialization of their proprietary products, from gram-scale requirements for clinical trials to launch and late life cycle management. The company's subsidiaries are Divis Laboratories (USA) Inc and Divi's Laboratories Europe AG.

Divi's Laboratories FAQs

How to Buy Divi's Laboratories Share?

virtual
To purchase Divi's Laboratories shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Divi's Laboratories (ticker symbol: divislab) on the trading platform provided by your broker and purchase the shares.

What's Divi's Laboratories share price today?

virtual
The stock price of Divi's Laboratories as of 24 May 2024 is ₹4,134.55

What is the Market Cap of Divi's Laboratories?

virtual
Market capitalisation represents the total market value of a company's outstanding shares. As of 24 May 2024, Divi's Laboratories (ticker symbol: divislab) has a market capitalisation of approximately ₹8,89,82,41,33,302.00

What is the PE and PB ratio of Divi's Laboratories?

virtual
Divi's Laboratories Ltd's price-to-book ratio as of 24 May 2024 is 9.983163, reflecting the market's valuation compared to its asset value. As of 24 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 39.567066, indicating the market values the company at around ₹39.57 for every ₹1 of earnings

What is the 52 Week High and Low of Divi's Laboratories Share?

virtual
Divi's Laboratories Ltd (divislab) hit its 52-week high at ₹4,127.55, and its 52-week low at { ₹3,295.30}.
Want to learn and earn in Stocks?